Medication use during pregnancy in Omani women

Intisar M. Al-Riyami, Intisar Q. Al-Busaidy, Ibrahim S. Al-Zakwani

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective The aim of this study was to evaluate medication use pattern in a university tertiary hospital in the Sultanate of Oman. Setting The study was conducted at the Sultan Qaboos University Hospital (SQUH) and the SQUH Family and Community Medicine clinic (FAMCO), Muscat, Sultanate of Oman during 7th to 25th June 2008. Method The medication use pattern was evaluated in women attending FAMCO and the standard antenatal clinics at the hospital. Women were interviewed in different gestational ages using a structured questionnaire. The Electronic Patient Record (EPR) was reviewed to acquire additional information on medication use. Medications were classified according to the US FDA risk classification. Main outcome measure Medication used including prescribed medications, OTC medications, or herbal treatment during the current pregnancy and 3 months prior to conception. Results The study included a total of 139 pregnant mothers with an overall mean age of 28 ± 5 years ranging from 19 to 45 years. There was a slight overall reduction in the medication use including prescribed medications. However, there was a significant increase in utilization of vitamins and supplements (84-95% vs. 12% in the 3-months prior, P <0.001) as well as herbal preparations (16-19% vs. 7% in the 3-months prior, P = 0.011) throughout pregnancy (P <0.010). The use of category A medications increased in all trimester (43-52% vs. 13% in the 3 months prior, P <0.010) while a reduction in the use of category C (for first and third trimester, P <0.050) and D medications was seen. A reduction in the use of teratogenic drugs in all trimesters (P <0.010) was also observed. Conclusion The prescribing of vitamins and minerals was optimal. However, the common use of herbal supplements observed warrants special attention due to their unknown risks. The conclusions should be interpreted in light of the study's limitations

Original languageEnglish
Pages (from-to)634-641
Number of pages8
JournalInternational Journal of Clinical Pharmacy
Volume33
Issue number4
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Oman
Vitamins
Pregnancy
Community Medicine
Hospital Medicine
Plant Preparations
Third Pregnancy Trimester
First Pregnancy Trimester
Tertiary Care Centers
Gestational Age
Minerals
Mothers
Outcome Assessment (Health Care)
Medicine
Pharmaceutical Preparations
Sultan
Therapeutics
Surveys and Questionnaires

Keywords

  • FDA pregnancy risk category
  • Medication
  • Oman
  • Pregnancy

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmaceutical Science
  • Pharmacology
  • Toxicology
  • Pharmacy

Cite this

Medication use during pregnancy in Omani women. / Al-Riyami, Intisar M.; Al-Busaidy, Intisar Q.; Al-Zakwani, Ibrahim S.

In: International Journal of Clinical Pharmacy, Vol. 33, No. 4, 08.2011, p. 634-641.

Research output: Contribution to journalArticle

Al-Riyami, Intisar M. ; Al-Busaidy, Intisar Q. ; Al-Zakwani, Ibrahim S. / Medication use during pregnancy in Omani women. In: International Journal of Clinical Pharmacy. 2011 ; Vol. 33, No. 4. pp. 634-641.
@article{acecbd9086b042aaa72809bf1343c2af,
title = "Medication use during pregnancy in Omani women",
abstract = "Objective The aim of this study was to evaluate medication use pattern in a university tertiary hospital in the Sultanate of Oman. Setting The study was conducted at the Sultan Qaboos University Hospital (SQUH) and the SQUH Family and Community Medicine clinic (FAMCO), Muscat, Sultanate of Oman during 7th to 25th June 2008. Method The medication use pattern was evaluated in women attending FAMCO and the standard antenatal clinics at the hospital. Women were interviewed in different gestational ages using a structured questionnaire. The Electronic Patient Record (EPR) was reviewed to acquire additional information on medication use. Medications were classified according to the US FDA risk classification. Main outcome measure Medication used including prescribed medications, OTC medications, or herbal treatment during the current pregnancy and 3 months prior to conception. Results The study included a total of 139 pregnant mothers with an overall mean age of 28 ± 5 years ranging from 19 to 45 years. There was a slight overall reduction in the medication use including prescribed medications. However, there was a significant increase in utilization of vitamins and supplements (84-95{\%} vs. 12{\%} in the 3-months prior, P <0.001) as well as herbal preparations (16-19{\%} vs. 7{\%} in the 3-months prior, P = 0.011) throughout pregnancy (P <0.010). The use of category A medications increased in all trimester (43-52{\%} vs. 13{\%} in the 3 months prior, P <0.010) while a reduction in the use of category C (for first and third trimester, P <0.050) and D medications was seen. A reduction in the use of teratogenic drugs in all trimesters (P <0.010) was also observed. Conclusion The prescribing of vitamins and minerals was optimal. However, the common use of herbal supplements observed warrants special attention due to their unknown risks. The conclusions should be interpreted in light of the study's limitations",
keywords = "FDA pregnancy risk category, Medication, Oman, Pregnancy",
author = "Al-Riyami, {Intisar M.} and Al-Busaidy, {Intisar Q.} and Al-Zakwani, {Ibrahim S.}",
year = "2011",
month = "8",
doi = "10.1007/s11096-011-9517-y",
language = "English",
volume = "33",
pages = "634--641",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7703",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Medication use during pregnancy in Omani women

AU - Al-Riyami, Intisar M.

AU - Al-Busaidy, Intisar Q.

AU - Al-Zakwani, Ibrahim S.

PY - 2011/8

Y1 - 2011/8

N2 - Objective The aim of this study was to evaluate medication use pattern in a university tertiary hospital in the Sultanate of Oman. Setting The study was conducted at the Sultan Qaboos University Hospital (SQUH) and the SQUH Family and Community Medicine clinic (FAMCO), Muscat, Sultanate of Oman during 7th to 25th June 2008. Method The medication use pattern was evaluated in women attending FAMCO and the standard antenatal clinics at the hospital. Women were interviewed in different gestational ages using a structured questionnaire. The Electronic Patient Record (EPR) was reviewed to acquire additional information on medication use. Medications were classified according to the US FDA risk classification. Main outcome measure Medication used including prescribed medications, OTC medications, or herbal treatment during the current pregnancy and 3 months prior to conception. Results The study included a total of 139 pregnant mothers with an overall mean age of 28 ± 5 years ranging from 19 to 45 years. There was a slight overall reduction in the medication use including prescribed medications. However, there was a significant increase in utilization of vitamins and supplements (84-95% vs. 12% in the 3-months prior, P <0.001) as well as herbal preparations (16-19% vs. 7% in the 3-months prior, P = 0.011) throughout pregnancy (P <0.010). The use of category A medications increased in all trimester (43-52% vs. 13% in the 3 months prior, P <0.010) while a reduction in the use of category C (for first and third trimester, P <0.050) and D medications was seen. A reduction in the use of teratogenic drugs in all trimesters (P <0.010) was also observed. Conclusion The prescribing of vitamins and minerals was optimal. However, the common use of herbal supplements observed warrants special attention due to their unknown risks. The conclusions should be interpreted in light of the study's limitations

AB - Objective The aim of this study was to evaluate medication use pattern in a university tertiary hospital in the Sultanate of Oman. Setting The study was conducted at the Sultan Qaboos University Hospital (SQUH) and the SQUH Family and Community Medicine clinic (FAMCO), Muscat, Sultanate of Oman during 7th to 25th June 2008. Method The medication use pattern was evaluated in women attending FAMCO and the standard antenatal clinics at the hospital. Women were interviewed in different gestational ages using a structured questionnaire. The Electronic Patient Record (EPR) was reviewed to acquire additional information on medication use. Medications were classified according to the US FDA risk classification. Main outcome measure Medication used including prescribed medications, OTC medications, or herbal treatment during the current pregnancy and 3 months prior to conception. Results The study included a total of 139 pregnant mothers with an overall mean age of 28 ± 5 years ranging from 19 to 45 years. There was a slight overall reduction in the medication use including prescribed medications. However, there was a significant increase in utilization of vitamins and supplements (84-95% vs. 12% in the 3-months prior, P <0.001) as well as herbal preparations (16-19% vs. 7% in the 3-months prior, P = 0.011) throughout pregnancy (P <0.010). The use of category A medications increased in all trimester (43-52% vs. 13% in the 3 months prior, P <0.010) while a reduction in the use of category C (for first and third trimester, P <0.050) and D medications was seen. A reduction in the use of teratogenic drugs in all trimesters (P <0.010) was also observed. Conclusion The prescribing of vitamins and minerals was optimal. However, the common use of herbal supplements observed warrants special attention due to their unknown risks. The conclusions should be interpreted in light of the study's limitations

KW - FDA pregnancy risk category

KW - Medication

KW - Oman

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=80052409277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052409277&partnerID=8YFLogxK

U2 - 10.1007/s11096-011-9517-y

DO - 10.1007/s11096-011-9517-y

M3 - Article

VL - 33

SP - 634

EP - 641

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7703

IS - 4

ER -